Two Sigma Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-58,688
Closed -$3.18M 2208
2014
Q4
$3.18M Sell
58,688
-24,104
-29% -$1.34M 0.02% 643
2014
Q3
$4.68M Buy
82,792
+28,296
+52% +$1.59M 0.04% 522
2014
Q2
$3.01M Buy
54,496
+49,256
+940% +$2.69M 0.02% 639
2014
Q1
$284K Sell
5,240
-287,152
-98% -$14.9M ﹤0.01% 1906
2013
Q4
$14M Sell
292,392
-110,040
-27% -$5.03M 0.13% 164
2013
Q3
$18.3M Buy
402,432
+348,250
+643% +$15.9M 0.22% 96
2013
Q2
$2.4M Buy
+54,182
New +$2.42M 0.03% 454

Other funds holding MRK

Two Sigma Advisers's MRK Position: Q4 2025 in Review

Two Sigma Advisers sold out of Merck (MRK) in Q4 2025, closing a stake of 2,320,900 shares — an estimated $195M sold.

Two Sigma Advisers first reported a position in MRK in Q3 2013 and held it in 48 quarters. The position peaked at $515M in Q4 2023. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Two Sigma Advisers reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 2,320,900 Merck shares in Q4 2025, an estimated $195M.
  • Two Sigma Advisers first reported a position in Merck in Q3 2013 and held it in 48 quarters.
  • Two Sigma Advisers's Merck position peaked at $515M in Q4 2023.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.